Dr. George Munoz, M.D.
What this data tells you about Dr. Munoz
Dr. George Munoz is a rheumatology specialist in Miami, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Munoz performed 71,255 Medicare services across 804 unique beneficiaries.
Between the years covered by Open Payments, Dr. Munoz received a total of $186,460 from 33 pharmaceutical and/or device companies across 605 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Munoz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 46,400 | $4 | $11 |
| Golimumab infusion (Simponi Aria) | 9,000 | $11 | $27 |
| Abatacept infusion (Orencia) | 8,925 | $34 | $84 |
| Denosumab injection (Prolia/Xgeva) | 5,100 | $18 | $43 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 385 | $57 | $189 |
| Administration of chemotherapy into vein, 1 hour or less | 198 | $106 | $345 |
| Injection of additional new drug or substance into vein | 180 | $13 | $85 |
| Office visit, established patient (30-39 min) | 130 | $99 | $270 |
| Injection, zoledronic acid, 1 mg | 125 | $6 | $17 |
| Injection, ketorolac tromethamine, per 15 mg | 98 | $0 | $5 |
| Office visit, established patient, complex (40-54 min) | 83 | $149 | $364 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 79 | $4 | $60 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 65 | $14 | $28 |
| X-ray of hand, minimum of 3 views | 63 | $31 | $77 |
| X-ray of wrist, minimum of 3 views | 62 | $33 | $100 |
| New patient office visit (45-59 min) | 61 | $137 | $415 |
| Complete ultrasound scan of joint | 47 | $34 | $290 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 45 | $49 | $270 |
| X-ray of knee, 4 or more views | 41 | $38 | $123 |
| Injection, diphenhydramine hcl, up to 50 mg | 37 | $1 | $3 |
| Drug injection, under skin or into muscle | 29 | $11 | $64 |
| X-ray of pelvis, 1-2 views | 26 | $23 | $80 |
| X-ray of lower and sacral spine, 2-3 views | 22 | $31 | $88 |
| Shoulder X-ray, 2+ views | 22 | $29 | $73 |
| Bone density scan (DEXA) | 19 | $40 | $104 |
| New patient office visit, complex (60-74 min) | 13 | $190 | $521 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for rheumatology in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Munoz is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 6% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Munoz experienced with certolizumab injection (cimzia)?
Does Dr. Munoz receive payments from pharmaceutical companies?
How do Dr. Munoz's costs compare to other rheumatologists in Miami?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology